查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869678

栓塞治疗市场规模、份额和趋势分析报告：按产品、应用、最终用途、地区和细分市场预测（2025-2033 年）

Embolotherapy Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10个工作天内

价格

栓塞市场摘要

2024年全球栓塞治疗市场规模估计为31.6亿美元，预计2033年将达到58.2亿美元。

预计从 2025 年到 2033 年，该市场将以 6.99% 的复合年增长率成长。该市场的主要成长要素是癌症、血管疾病和创伤病例的增加，这些因素推动了对微创治疗方法的需求。

栓塞剂（如药物释放型珠、液体栓塞剂和生物可吸收微球）的技术进步，以及创新输送装置（如微导管和血流导向装置）的出现，提高了手术的精确性、安全性和临床疗效。

此外，患者越来越倾向于选择恢復时间更短的微创手术，新兴市场医疗基础设施不断扩大，以及有利的法规结构，这些因素共同推动了微创手术的进一步普及，为持续增长创造了机会，并巩固了市场的上升趋势。

全球癌症治疗、创伤病例和血管疾病的增加推动了对先进栓塞解决方案的需求。医院、诊所和介入放射中心的手术量不断增长，对高效栓塞剂和输送系统的需求也随之持续增加。这一趋势进一步促使医疗机构采用创新、微创的技术，在确保安全性和效率的同时改善患者预后。为了满足这些需求，医疗机构正在加速向下一代栓塞技术转型，以实现更快的手术速度、更高的精准度和更少的併发症。

例如，2025年6月，Penumbra公司宣布推出Ruby XL系统，这是目前市场上最长、最大、最灵活的栓塞系统，并已获得美国食品药物管理局（FDA）的核准。 Ruby XL系统旨在帮助医生更有效率地进行栓塞手术，从而可能减少辐射曝射量并改善治疗效果，尤其是在涉及大血管或高流量栓塞的手术中。

癌症和血管疾病发生率的上升是栓塞治疗产业的主要驱动力，因为这些疾病通常需要标靶性、微创治疗来控制出血、缩小肿瘤体积或处理异常血管。肝癌患者经常接受经动脉栓塞术，以阻断肿瘤的血液供应并减缓肿瘤生长，同时保护周围健康组织。由于恢復时间短、併发症少，栓塞术也越来越多地被用作动静脉畸形和消化道出血等疾病的有效替代开放性手术。根据世界卫生组织估计，2022年至2040年间，男性和女性（0-85岁及以上）肝癌和肝内胆管癌的新病例数预计将会增加。详情请见下方资料框和图表。

目录

第一章调查方法和范围

第二章执行摘要

3.栓塞治疗市场变数、趋势和范围

  • 市场体系展望
    • 补贴市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 栓塞治疗市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章 栓塞治疗市场：依产品分類的估计与趋势分析

  • 细分仪表板
  • 产品差异分析及市占率（2024 年及 2033 年）
  • 栓塞线圈
  • 栓塞剂
    • 分流器
    • 可拆卸气球
    • 血管栓塞器/栓塞系统
    • 支援的设备

第五章 栓塞治疗市场：按应用分類的估计与趋势分析

  • 细分仪表板
  • 按应用领域分類的趋势分析和市场份额（2024 年和 2033 年）
  • 肿瘤学
  • 週边血管疾病
  • 神经血管异常
  • 子宫肌瘤栓塞术
  • 创伤与出血控制
  • 其他的

第六章：栓塞治疗市场：依最终用途分類的估计与趋势分析

  • 细分仪表板
  • 2024 年和 2033 年按最终用途分類的变化分析和市场份额
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第七章：栓塞治疗市场：区域估计与趋势分析

  • 区域展望
  • 2024年及2033年区域动态分析及市场份额
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • Medtronic
    • Johnson &Johnson
    • B. Braun SE
    • Terumo
    • Boston Scientific Corporation
    • Meril
    • Gem srl
    • Balt
    • Sirtex（BlackSwan Vascular, Inc.）
    • INVAMED
    • Stryker
    • Penumbra
    • Merit Medical Systems
    • Abbott
    • Acandis GmbH
    • Cook Medical
Product Code: GVR-4-68040-763-5

Embolotherapy Market Summary

The global embolotherapy market size was estimated at USD 3.16 billion in 2024 and is projected to reach USD 5.82 billion by 2033, growing at a CAGR of 6.99% from 2025 to 2033. The market is primarily driven by the rising prevalence of cancer, vascular disorders, and trauma cases, which fuel demand for minimally invasive treatment options.

Technological advancements in embolic agents, such as drug-eluting beads, liquid embolic, and bioresorbable microspheres, along with innovative delivery devices like microcatheters and flow diverters, have improved procedural precision, safety, and clinical outcomes.

Moreover, increasing patient preference for less invasive procedures with shorter recovery times, expanding healthcare infrastructure in emerging markets, and supportive regulatory frameworks further accelerate adoption. Together, these factors create sustained growth opportunities and reinforce the market's upward trajectory.

The global rise in cancer treatments, trauma cases, and vascular disorders has amplified the need for advanced embolotherapy solutions. Hospitals, clinics, and interventional radiology centers are witnessing growing procedure volumes, creating continuous demand for effective embolic agents and delivery systems. This trend places additional pressure on healthcare facilities to adopt innovative, minimally invasive techniques that improve patient outcomes while maintaining safety and efficiency. To meet these needs, providers are increasingly turning to next-generation embolotherapy technologies that enable faster procedures, greater precision, and reduced complications.

For instance, in June 2025, Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) had cleared and launched the Ruby XL System, the longest, largest, and softest coil available on the market. The Ruby XL System is designed to enable physicians to perform more efficient embolizations, potentially decreasing radiation exposure and improving outcomes-particularly in procedures involving large vessels and high-flow embolizations.

The rising prevalence of cancer and vascular diseases is a major driver of the embolotherapy industry because these conditions often require targeted, minimally invasive treatments to control bleeding, reduce tumor size, or manage abnormal blood vessels. Patients with liver cancer frequently undergo transarterial embolization to block the blood supply to tumors, slowing their growth while preserving surrounding healthy tissue. Arteriovenous malformations or gastrointestinal bleeding cases are increasingly managed with embolotherapy, as it provides an effective alternative to open surgery with shorter recovery times and fewer complications. According to WHO, the estimated number of new cases of liver and intrahepatic bile duct cancers among both sexes (ages 0-85+) is projected to increase from 2022 to 2040, as shown in the data frame and illustrated in the graph below.

Global Embolotherapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global embolotherapy market report based on the product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Embolization Coils
    • Detachable Coils
    • Pushable Coils
  • Embolic Agents
    • Liquid Embolic Agents
    • Ethylene Vinyl Alcohol Copolymer (EVOH)
    • N-BCA (n-Butyl Cyanoacrylate)
    • N-HCA (n-Hexyl Cyanoacrylate)
    • Cyanoacrylates
    • Others
    • Microspheres
  • Flow Diverters
  • Detachable Balloons
  • Vascular Plugs/Plug Systems
  • Support Devices
    • Guidewires
    • Microcatheters
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
    • Liver Cancer (Hepatocellular carcinoma)
    • Renal Cell Carcinoma
    • Lung Cancer
    • Others
  • Peripheral Vascular Diseases
  • Neurovascular Abnormalities
  • Uterine Fibroid Embolization
  • Trauma and Bleeding Control
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End-Use
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased database.
  • 1.5. GVR's internal database
  • 1.6. Secondary sources
  • 1.7. Third Party Perspective
  • 1.8. Primary research
  • 1.9. Details of primary research
    • 1.9.1. Information or Data Analysis
    • 1.9.2. Data analysis models
    • 1.9.3. Market Formulation & Validation
    • 1.9.4. Model Details
  • 1.10. Commodity flow analysis (Model 1)
    • 1.10.1. Approach 1: Commodity flow approach
  • 1.11. Volume price analysis (Model 2)
    • 1.11.1. Approach 2: Volume price analysis
  • 1.12. List of Secondary Sources
  • 1.13. List of Primary Sources
  • 1.14. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Embolotherapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of cancer and vascular diseases
      • 3.2.1.2. Technological advancements in embolic agents and devices
      • 3.2.1.3. Increasing trauma and hemorrhage cases
      • 3.2.1.4. Growing preference for minimally invasive procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of complications
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Development of novel embolic agents
      • 3.2.3.2. Rising adoption of minimally invasive procedures
      • 3.2.3.3. Expansion into emerging markets
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. High cost of procedures and devices
  • 3.3. Embolotherapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power of Suppliers
      • 3.3.1.2. Bargaining Power of Buyers
      • 3.3.1.3. Threat of Substitutes
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. Embolotherapy Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Embolotherapy Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Embolization Coils
    • 4.3.1. Embolization Coils Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.1. Detachable Coils
        • 4.3.1.1.1. Detachable Coils Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Pushable Coils
        • 4.3.1.2.1. Pushable Coils Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Embolic Agents
    • 4.4.1. Embolic Agents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Liquid Embolic Agents
        • 4.4.1.1.1. Ethylene Vinyl Alcohol Copolymer (EVOH) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.1.1. N-BCA (n-Butyl Cyanoacrylate)
          • 4.4.1.1.1.2. N-HCA (n-Hexyl Cyanoacrylate)
        • 4.4.1.1.2. Cyanoacrylates Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.1.1.3. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.2. Microspheres
        • 4.4.1.2.1. Microspheres Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Flow Diverters
      • 4.4.2.1. Flow Diverters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Detachable Balloons
      • 4.4.3.1. Detachable Balloons Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Vascular Plugs/Plug Systems
      • 4.4.4.1. Vascular Plugs/Plug Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Support Devices
      • 4.4.5.1. Support Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.5.1.1. Guidewires
          • 4.4.5.1.1.1. Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.5.1.2. Microcatheters
          • 4.4.5.1.2.1. Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Embolotherapy Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Embolotherapy Market: Application Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Oncology
    • 5.3.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Peripheral Vascular Diseases
    • 5.4.1. Peripheral Vascular Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Neurovascular Abnormalities
    • 5.5.1. Neurovascular Abnormalities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Uterine Fibroid Embolization
    • 5.6.1. Uterine Fibroid Embolization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Trauma and Bleeding Control
    • 5.7.1. Trauma and Bleeding Control Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Embolotherapy Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Embolotherapy Market: End Use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Hospitals and Clinics
    • 6.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Ambulatory Surgical Centers
    • 6.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Embolotherapy Market: Regional Estimates & Trend Analysis by Product, Application, End Use

  • 7.1. Regional Outlook
  • 7.2. Embolotherapy Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Johnson & Johnson
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. B. Braun SE
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Terumo
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Boston Scientific Corporation
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Meril
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Gem srl
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Balt
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Sirtex (BlackSwan Vascular, Inc.)
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiative
    • 8.2.10. INVAMED
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. Stryker
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Penumbra
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Product Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. Merit Medical Systems
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Product Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Abbott
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Product Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Acandis GmbH
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Product Benchmarking
      • 8.2.15.4. Strategic Initiatives
    • 8.2.16. Cook Medical
      • 8.2.16.1. Company Overview
      • 8.2.16.2. Financial Performance
      • 8.2.16.3. Product Benchmarking
      • 8.2.16.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global embolotherapy market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 9 North America embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 10 US embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 11 US embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 12 US embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 25 UK embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 28 Germany embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 30 France embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 31 France embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 34 Italy embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 37 Spain embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 39 Denmark embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 40 Denmark embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 43 Sweden embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 45 Norway embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 46 Norway embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 52 China embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 53 China embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 55 Japan embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 58 India embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 59 India embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 64 Australia embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 79 MEA embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait embolotherapy market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Embolotherapy market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Embolotherapy market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping, by distribution channel
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Embolization coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Detachable coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Pushable coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Embolic agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Liquid embolic agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Ethylene vinyl alcohol copolymer (EVOH) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 N-butyl cyanoacrylate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 N-hexyl cyanoacrylate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Cyanoacrylates market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Microspheres market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Flow diverters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Detachable balloons market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Vascular plugs/plug systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Support devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Microcatheters systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Oncology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Liver cancer (hepatocellular carcinoma) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Renal cell carcinoma market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Lung cancer market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Peripheral Vascular Diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Neurovascular abnormalities market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Uterine fibroid embolization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Trauma and bleeding control market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Hospitals and clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Other end-use market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Embolotherapy market: Regional key takeaways (USD Million)
  • Fig. 44 Embolotherapy market: Regional outlook, 2024 & 2033, USD Million
  • Fig. 45 North America embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 US embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Canada embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Mexico embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Europe embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 UK embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Germany embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 France embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Spain embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Italy embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Sweden embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Norway embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Denmark embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Asia Pacific embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 China embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Japan embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 India embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Australia embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Latin America embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Brazil embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Middle East and Africa embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 South Africa embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Saudi Arabia embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 UAE embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Kuwait embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 List of key emerging companies
  • Fig. 74 Company market share analysis, 2024
  • Fig. 75 Market differentiators
  • Fig. 76 Competitive dashboard analysis
  • Fig. 77 Regional network map